Management Strategies for Cervical Esophageal Cancer

Cervical esophageal cancer, arising between the cricoid cartilage and the thoracic inlet, poses unique therapeutic challenges owing to its proximity to the larynx, thyroid and upper aerodigestive tract. Multimodal management is the cornerstone of care and seeks to balance oncological control with preservation of speech and swallowing. Definitive chemoradiotherapy has become the predominant strategy for squamous cell carcinoma in this region, combining platinum-based chemotherapy with intensity-modulated techniques to maximise tumour dose while sparing normal structures. Surgical approaches, once dominated by laryngopharyngectomy, now increasingly incorporate organ-preserving techniques following neoadjuvant chemoradiation in carefully selected patients. Radiotherapy field design has evolved from wide elective nodal irradiation to more selective involved-field irradiation, reducing toxicity without compromising locoregional control. Emerging evidence supports dose escalation to gross disease and tailored nodal coverage based on pretreatment imaging. A multidisciplinary team, including head and neck surgeons, radiation and medical oncologists, speech and swallowing therapists, is essential for individualised decision-making. Across high- and low-income settings, advances in target delineation, treatment planning and supportive care have improved functional outcomes and long-term survival, although late toxicities such as hypothyroidism and cardiovascular sequelae warrant sustained surveillance.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Management Strategies for Cervical Esophageal Cancer publication trend

The graph below shows the total number of articles in management strategies for cervical esophageal cancer across all publications each year (not limited to Nature Index journals).

Technical terms

Cervical esophageal carcinoma: Malignancy arising in the upper segment of the oesophagus, from the cricoid cartilage to the thoracic inlet.

Chemoradiotherapy (CRT): Combined modality treatment integrating cytotoxic chemotherapy with concurrent radiotherapy to enhance tumour cell kill.

Elective nodal irradiation (ENI): Radiotherapy approach that prophylactically treats lymph node regions at risk of microscopic involvement.

Involved-field irradiation (IFI): Radiotherapy design targeting only gross tumour and clinically involved nodes, sparing elective nodal areas.

Larynx preservation surgery: Surgical strategy following neoadjuvant therapy that aims to resect tumour while conserving voice and swallowing function.

References

1. Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023).
2. A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer. Acta Oncologica (2020).
3. Neoadjuvant Chemoradiotherapy and Larynx-Preserving Surgery for Cervical Esophageal Cancer. Journal of Clinical Medicine (2020).